Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This reflects a version update and does not modify study content or displayed information.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows a revision update from v3.6.2 to v3.6.3, indicating a new build or update of the page rather than new substantive information.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page shows a new minor version revision tag (v3.6.2) replacing the previous v3.6.0. This indicates a platform update that does not affect the study data or its presentation.SummaryDifference0.0%

- Check56 days agoChange DetectedNew recruitment status and help/navigation sections were added, including 'No longer looking for participants' and 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The page also updates the labeling of 'Intervention/Treatment' and updates the revision note to 'Revision: v3.6.0' (replacing v3.5.5).SummaryDifference0.4%

- Check64 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small update to the page's underlying document/template.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page revision label has been updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This update does not modify the study details or surrounding content.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.